The sales are small relative to market cap and conducted under 10b5-1 plans, so they carry limited directional signal. The CEO's exercise-and-sell pattern is typical for option monetization. Monitor for any unplanned insider sales in the coming weeks that could indicate a change in sentiment.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $104.01entry
- T+1 · 6d ago +1.73%α +0.41% · $105.81
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Edwards Lifesciences insiders, including the CEO, executed open-market sales totaling approximately $5.99M on November 9, 2026, following the company's Q3 earnings beat and raised guidance reported on November 4. Both sales were conducted under 10b5-1 trading plans, and the CEO's sale was part of a same-day exercise-and-sell transaction. The total value represents about 0.01% of the company's $57.9B market cap, making the cluster economically trivial.
Key Financial Metrics
Key Facts
- CEO Bernard Zovighian sold 23,100 shares in two open-market trades totaling $2.38M on Nov 9, 2026
- CVP Donald Bobo Jr. sold 48,900 shares for $5.04M on Nov 9, 2026
- Both sales were executed under 10b5-1 trading plans
- The CEO's sale was part of a same-day derivative exercise (23,100 options exercised at $72.68)
- Total open-market sales of $5.99M represent ~0.01% of EW's $57.9B market cap
- Sales occurred 5 days after Q3 2026 earnings beat (adj. EPS $0.80 vs $0.74 consensus) and raised guidance
Financial Impact
Open-market sales of $5.99M, or ~0.01% of market cap
Risk Factors
- Insider sales under 10b5-1 plans are pre-scheduled and not necessarily reflective of current views
- The CEO's option exercise and immediate sale is a routine cashless exercise pattern
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1794259781849 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Viewing Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers